Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AVE0010 add-on to basal insulin in type 2 diabetes
2007-005886-36Phase 3Completed
- Sponsor
- Sanofi
- Start
- Sep 2008
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing AVE0010 + basal insulin with Placebo + basal insulin (2 arms). Primary endpoint: Absolute change of HbA1c from baseline to week 24. Started Sep 2008; status: completed.
02
Drugs
lixisenatide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2007-005886-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005886-36.